A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus

Neurosurgery

Volumn 67, Issue 5, 2010, Pages 1303-1310

  Steinbok, Paul ^a   Milner, Ruth ^b   Agrawal, Deepak ^c   Farace, Elana ^d   Leung, Gilberto K K ^e   Ng, Ivan ^f   Tomita, Tadanori ^g   Wang, Ernest ^f   Wang, Ning ^h   Chu Wong, George Kwok ⁱ   Zhou, Liang Fu ^j  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^g NORTHWESTERN UNIVERSITY   (United States)

^h CAPITAL MEDICAL UNIVERSITY   (China)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j FUDAN UNIVERSITY   (China)

more..

Author keywords

Antibiotic impregnated catheters; Hydrocephalus; Shunt infection; Shunt registry; Ventriculoperitoneal shunt

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC IMPREGNATED CATHETER; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CATHETER; CATHETERIZATION; CHILD; FEMALE; HUMAN; HYDROCEPHALUS; IMPLANT REGISTRY; INFANT; INFECTION RATE; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; SHUNT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; VENTRICULOPERITONEAL SHUNT; YOUNG ADULT;

EID: 77958455852     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181f07e76     Document Type: Article

References (26)

1. Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg. 1997;87(2):247-251.
2. Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery. 1998;43(2):294-303; discussion 303-295.
3. Kestle JR, Drake JM, Cochrane DD, et al. Lack of benefit of endoscopic ven-triculoperitoneal shunt insertion: a multicenter randomized trial. J Neurosurg. 2003;98(2):284-290.
4. Sciubba DM, Stuart RM, McGirt MJ, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hy-drocephalus. J Neurosurg. 2005;103(2 Suppl):131-136.
5. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML. Initial experience with antibiotic-impregnated silicone catheters for shunting of cere-brospinal fluid in children. Childs Nerv Syst. 2005;21(1):56-61.
6. Govender ST, Nathoo N, Van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg. 2003;99(5):831-839.
7. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci. 2007;14(6):526-531.
8. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst. 2008;24(5):557-562.
9. Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst. 2007;23(7):773-777.
10. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis. 2007;7:38.
11. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975;131(5):543-552.
12. Drake JM, Sainte-Rose C. The Shunt Book. Cambridge, Massachusetts: Blackwell Science; 1995.
13. Federal Register. 1997;62, #90; May 9, 1997:25691-25709.
14. Health Canada. Departmental Consolidation of the Food and Drugs Act and of the Food and Drug Regulations. Issued by the Department of Health, Minister of Public Works and Government Services Canada, June 2002.
15. Bayston R. Hydrocephalus Shunt Infections. London: Chapman and Hall; 1989.
16. Kestle JR, Garton HJ, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg. 2006;105(3 Suppl):177-181.
17. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydro-cephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989;52(5):605-609.
18. Kockro RA, Hampl JA, Jansen B, et al. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol. 2000;49(5):441-450.
19. Kohnen W, Kolbenschlag C, Teske-Keiser S, Jansen B. Development of a long-lasting ventricular catheter impregnated with a combination of antibiotics. Biomaterials. 2003;24(26):4865-4869.
20. Schierholz JM, Pulverer G. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol. 1997;286(1):107-123.
21. Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother. 2004;53(5):778-782.
22. Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A. Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery. 2006;58(5):930-935; discussion 930-935.
23. Parker SL, Attenello FJ, Sciubba DM, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst. 2009;25(1):77-83; discussion 85.
24. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst. 2007;23(8):867-871.
25. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Anti-microb Chemother. 2007;59(3):359-369.
26. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725-730.